Keyword Analysis & Research: celularity


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
celularity1.440.177487110

Keyword Research: People who searched celularity also searched

Keyword CPC PCC Volume Score
celularity1.360.8579040
celularity stock0.680.3813880
celularity company21631795
celularity linkedin1.690.9257776
celularity news1.10.7819561
celularity stock price0.130.7392252
celularity stock yahoo1.280.728434
celularity share price0.050.6956855
celularity biosourcing0.93175074
celularity incorporated1.840.15529
celularity cynk-0010.640.1225423
celularity address1.120.898074

Search Results related to celularity on Search Engine

  • Celularity – The Next Evolution in Cellular Medicine

    celularity.com

    https://celularity.com/

    WEBCelularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases.

    DA: 10 PA: 19 MOZ Rank: 79

  • About – Celularity

    celularity.com

    https://celularity.com/about/

    WEBCelularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases.

    DA: 4 PA: 20 MOZ Rank: 7

  • Pipeline – Celularity

    celularity.com

    https://celularity.com/pipeline/

    WEBCelularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases.

    DA: 64 PA: 91 MOZ Rank: 48

  • Celularity Inc. (CELU) - Yahoo Finance

    yahoo.com

    https://finance.yahoo.com/quote/CELU

    WEBCelularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It...

    DA: 85 PA: 92 MOZ Rank: 92

  • Celularity Inc. | LinkedIn

    linkedin.com

    https://www.linkedin.com/company/celularity

    WEBCelularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived...

    DA: 75 PA: 93 MOZ Rank: 93

  • Celularity and GX Acquisition Corp. Announce Merger Agreement …

    prnewswire.com

    https://www.prnewswire.com/news-releases/celularity-and-gx-acquisition-corp-announce-merger-agreement-to-create-a-publicly-listed-leader-in-allogeneic-cellular-therapy-301203341.html

    WEBJan 8, 2021 · Celularity is a clinical-stage biotechnology company leading the next evolution in cellular medicine with the development of allogeneic placental-derived cell therapy products, including...

    DA: 35 PA: 83 MOZ Rank: 70

  • Celularity Announces Clinical Data on Human - GlobeNewswire

    globenewswire.com

    https://www.globenewswire.com/news-release/2023/04/27/2656412/0/en/Celularity-Announces-Clinical-Data-on-Human-Placental-Derived-Unmodified-Allogeneic-Natural-Killer-Cell-Therapy-Candidate-Cynk-001-in-Adult-Patients-With-Relapsed-Refractory-and-Me.html

    WEBFLORHAM PARK, N.J., April 27, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products,...

    DA: 58 PA: 6 MOZ Rank: 29

  • Celularity Inc. – Celularity

    celularity.com

    https://celularity.com/author/celularitynew/

    WEBCelularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics.

    DA: 50 PA: 32 MOZ Rank: 46

  • Celularity Receives U.S. Food And Drug Administration (FDA)

    globenewswire.com

    https://www.globenewswire.com/news-release/2023/04/03/2639651/0/en/Celularity-Receives-U-S-Food-And-Drug-Administration-FDA-Preliminary-Assessment-For-Celularity-s-Investigational-Fuse-Bone-Void-Filler-To-Be-Regulated-As-A-Device-By-FDA-s-Center-F.html

    WEBFLORHAM PARK, N.J., April 03, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a biotechnology company developing placental-derived allogeneic cell...

    DA: 5 PA: 62 MOZ Rank: 87

  • Celularity’s Placental-Derived Allogeneic Cell Therapy

    globenewswire.com

    https://www.globenewswire.com/news-release/2023/01/06/2584421/0/en/Celularity-s-Placental-Derived-Allogeneic-Cell-Therapy-Provides-Clinically-Meaningful-Benefit-and-Durable-Biological-Effect-in-Patients-with-Moderate-to-Severe-Crohn-s-Disease-in-P.html

    WEBFLORHAM PARK, N.J., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity), a biotechnology company developing placental-derived allogeneic cell and biomaterial...

    DA: 52 PA: 57 MOZ Rank: 5